Fostamatinib, a Spleen Tyrosine Kinase Inhibitor, Exerts Anti-Inflammatory Activity via Inhibiting STAT1/3 Signaling Pathways
Ran Guo,1 Hanjing Liao,2 Yinuo Meng,3 Xiaoyi Shi,4 Yuting He,4 Zhixiang Zhu,2 Wenzhi Guo1,4 1Henan Key Laboratory of Digestive Organ Transplantation, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, 450052, People's Republic of China; 2Modern Research Center of Traditional Chin...
Saved in:
Main Authors: | Guo R (Author), Liao H (Author), Meng Y (Author), Shi X (Author), He Y (Author), Zhu Z (Author), Guo W (Author) |
---|---|
Format: | Book |
Published: |
Dove Medical Press,
2024-11-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Effects of a spleen tyrosine kinase inhibitor on progression of the lupus nephritis in mice
by: Maki Kitai, et al.
Published: (2017) -
Brusatol Derivative-34 Attenuates Allergic Airway Inflammation Via Inhibition of the Spleen Tyrosine Kinase Pathway
by: Yasi Ding, et al.
Published: (2021) -
Inhibition of Spleen Tyrosine Kinase Restores Glucocorticoid Sensitivity to Improve Steroid-Resistant Asthma
by: Qian Liu, et al.
Published: (2022) -
Cryptotanshinone enhances the efficacy of Bcr-Abl tyrosine kinase inhibitors via inhibiting STAT3 and eIF4E signalling pathways in chronic myeloid leukaemia
by: Rubin Cheng, et al.
Published: (2021) -
The Role of STAT5 in Tyrosine Kinase Inhibitor (IMATINIB) Resistance in CML Patients
by: Anastasia Putri, et al.
Published: (2019)